The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Leishmaniasis Treatment Market Research Report 2025

Global Leishmaniasis Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1707746

No of Pages : 70

Ask Your Query

Synopsis

A drug used to treat diseases caused by parasitic protozoa leishmania

The global Leishmaniasis Treatment market was valued at US$ 95 million in 2023 and is anticipated to reach US$ 137.9 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Leishmaniasis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leishmaniasis Treatment.

Report Scope

The Leishmaniasis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Leishmaniasis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Leishmaniasis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Merck
  • iCo Therapeutics
  • AEterna Zentaris
  • AEterna Zentaris AG
  • Eurofins Advinus
  • Pieris Pharmaceuticals
  • Dafra Pharma

Segment by Type

  • Meglumine Antimoniate
  • Pentamidine
  • Hydroxyl Amidine Stilbene
  • Amphotericin B

Segment by Application

  • Visceral Leishmaniasis
  • Cutaneous Leishmaniasis

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leishmaniasis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Leishmaniasis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Meglumine Antimoniate

1.2.3 Pentamidine

1.2.4 Hydroxyl Amidine Stilbene

1.2.5 Amphotericin B

1.3 Market by Application

1.3.1 Global Leishmaniasis Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Visceral Leishmaniasis

1.3.3 Cutaneous Leishmaniasis

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Leishmaniasis Treatment Market Perspective (2019-2030)

2.2 Leishmaniasis Treatment Growth Trends by Region

2.2.1 Global Leishmaniasis Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Leishmaniasis Treatment Historic Market Size by Region (2019-2024)

2.2.3 Leishmaniasis Treatment Forecasted Market Size by Region (2025-2030)

2.3 Leishmaniasis Treatment Market Dynamics

2.3.1 Leishmaniasis Treatment Industry Trends

2.3.2 Leishmaniasis Treatment Market Drivers

2.3.3 Leishmaniasis Treatment Market Challenges

2.3.4 Leishmaniasis Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Leishmaniasis Treatment Players by Revenue

3.1.1 Global Top Leishmaniasis Treatment Players by Revenue (2019-2024)

3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Leishmaniasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Leishmaniasis Treatment Revenue

3.4 Global Leishmaniasis Treatment Market Concentration Ratio

3.4.1 Global Leishmaniasis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Leishmaniasis Treatment Revenue in 2023

3.5 Leishmaniasis Treatment Key Players Head office and Area Served

3.6 Key Players Leishmaniasis Treatment Product Solution and Service

3.7 Date of Enter into Leishmaniasis Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Leishmaniasis Treatment Breakdown Data by Type

4.1 Global Leishmaniasis Treatment Historic Market Size by Type (2019-2024)

4.2 Global Leishmaniasis Treatment Forecasted Market Size by Type (2025-2030)

5 Leishmaniasis Treatment Breakdown Data by Application

5.1 Global Leishmaniasis Treatment Historic Market Size by Application (2019-2024)

5.2 Global Leishmaniasis Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Leishmaniasis Treatment Market Size (2019-2030)

6.2 North America Leishmaniasis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Leishmaniasis Treatment Market Size by Country (2019-2024)

6.4 North America Leishmaniasis Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Leishmaniasis Treatment Market Size (2019-2030)

7.2 Europe Leishmaniasis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Leishmaniasis Treatment Market Size by Country (2019-2024)

7.4 Europe Leishmaniasis Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Leishmaniasis Treatment Market Size (2019-2030)

8.2 Asia-Pacific Leishmaniasis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Leishmaniasis Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Leishmaniasis Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Leishmaniasis Treatment Market Size (2019-2030)

9.2 Latin America Leishmaniasis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Leishmaniasis Treatment Market Size by Country (2019-2024)

9.4 Latin America Leishmaniasis Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Leishmaniasis Treatment Market Size (2019-2030)

10.2 Middle East & Africa Leishmaniasis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Detail

11.1.2 Merck Business Overview

11.1.3 Merck Leishmaniasis Treatment Introduction

11.1.4 Merck Revenue in Leishmaniasis Treatment Business (2019-2024)

11.1.5 Merck Recent Development

11.2 iCo Therapeutics

11.2.1 iCo Therapeutics Company Detail

11.2.2 iCo Therapeutics Business Overview

11.2.3 iCo Therapeutics Leishmaniasis Treatment Introduction

11.2.4 iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2019-2024)

11.2.5 iCo Therapeutics Recent Development

11.3 AEterna Zentaris

11.3.1 AEterna Zentaris Company Detail

11.3.2 AEterna Zentaris Business Overview

11.3.3 AEterna Zentaris Leishmaniasis Treatment Introduction

11.3.4 AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2019-2024)

11.3.5 AEterna Zentaris Recent Development

11.4 AEterna Zentaris AG

11.4.1 AEterna Zentaris AG Company Detail

11.4.2 AEterna Zentaris AG Business Overview

11.4.3 AEterna Zentaris AG Leishmaniasis Treatment Introduction

11.4.4 AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2019-2024)

11.4.5 AEterna Zentaris AG Recent Development

11.5 Eurofins Advinus

11.5.1 Eurofins Advinus Company Detail

11.5.2 Eurofins Advinus Business Overview

11.5.3 Eurofins Advinus Leishmaniasis Treatment Introduction

11.5.4 Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2019-2024)

11.5.5 Eurofins Advinus Recent Development

11.6 Pieris Pharmaceuticals

11.6.1 Pieris Pharmaceuticals Company Detail

11.6.2 Pieris Pharmaceuticals Business Overview

11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Introduction

11.6.4 Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2019-2024)

11.6.5 Pieris Pharmaceuticals Recent Development

11.7 Dafra Pharma

11.7.1 Dafra Pharma Company Detail

11.7.2 Dafra Pharma Business Overview

11.7.3 Dafra Pharma Leishmaniasis Treatment Introduction

11.7.4 Dafra Pharma Revenue in Leishmaniasis Treatment Business (2019-2024)

11.7.5 Dafra Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

List of Tables

Table 1. Global Leishmaniasis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Meglumine Antimoniate

Table 3. Key Players of Pentamidine

Table 4. Key Players of Hydroxyl Amidine Stilbene

Table 5. Key Players of Amphotericin B

Table 6. Global Leishmaniasis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Leishmaniasis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Leishmaniasis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Leishmaniasis Treatment Market Share by Region (2019-2024)

Table 10. Global Leishmaniasis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Leishmaniasis Treatment Market Share by Region (2025-2030)

Table 12. Leishmaniasis Treatment Market Trends

Table 13. Leishmaniasis Treatment Market Drivers

Table 14. Leishmaniasis Treatment Market Challenges

Table 15. Leishmaniasis Treatment Market Restraints

Table 16. Global Leishmaniasis Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Leishmaniasis Treatment Market Share by Players (2019-2024)

Table 18. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2023)

Table 19. Ranking of Global Top Leishmaniasis Treatment Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Leishmaniasis Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Leishmaniasis Treatment Product Solution and Service

Table 23. Date of Enter into Leishmaniasis Treatment Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Leishmaniasis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Leishmaniasis Treatment Revenue Market Share by Type (2019-2024)

Table 27. Global Leishmaniasis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Leishmaniasis Treatment Revenue Market Share by Type (2025-2030)

Table 29. Global Leishmaniasis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Leishmaniasis Treatment Revenue Market Share by Application (2019-2024)

Table 31. Global Leishmaniasis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Leishmaniasis Treatment Revenue Market Share by Application (2025-2030)

Table 33. North America Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Leishmaniasis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Leishmaniasis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Leishmaniasis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Leishmaniasis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Leishmaniasis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Leishmaniasis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Leishmaniasis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 48. Merck Company Detail

Table 49. Merck Business Overview

Table 50. Merck Leishmaniasis Treatment Product

Table 51. Merck Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)

Table 52. Merck Recent Development

Table 53. iCo Therapeutics Company Detail

Table 54. iCo Therapeutics Business Overview

Table 55. iCo Therapeutics Leishmaniasis Treatment Product

Table 56. iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)

Table 57. iCo Therapeutics Recent Development

Table 58. AEterna Zentaris Company Detail

Table 59. AEterna Zentaris Business Overview

Table 60. AEterna Zentaris Leishmaniasis Treatment Product

Table 61. AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)

Table 62. AEterna Zentaris Recent Development

Table 63. AEterna Zentaris AG Company Detail

Table 64. AEterna Zentaris AG Business Overview

Table 65. AEterna Zentaris AG Leishmaniasis Treatment Product

Table 66. AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)

Table 67. AEterna Zentaris AG Recent Development

Table 68. Eurofins Advinus Company Detail

Table 69. Eurofins Advinus Business Overview

Table 70. Eurofins Advinus Leishmaniasis Treatment Product

Table 71. Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)

Table 72. Eurofins Advinus Recent Development

Table 73. Pieris Pharmaceuticals Company Detail

Table 74. Pieris Pharmaceuticals Business Overview

Table 75. Pieris Pharmaceuticals Leishmaniasis Treatment Product

Table 76. Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)

Table 77. Pieris Pharmaceuticals Recent Development

Table 78. Dafra Pharma Company Detail

Table 79. Dafra Pharma Business Overview

Table 80. Dafra Pharma Leishmaniasis Treatment Product

Table 81. Dafra Pharma Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)

Table 82. Dafra Pharma Recent Development

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Leishmaniasis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Leishmaniasis Treatment Market Share by Type: 2023 VS 2030

Figure 3. Meglumine Antimoniate Features

Figure 4. Pentamidine Features

Figure 5. Hydroxyl Amidine Stilbene Features

Figure 6. Amphotericin B Features

Figure 7. Global Leishmaniasis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Leishmaniasis Treatment Market Share by Application: 2023 VS 2030

Figure 9. Visceral Leishmaniasis Case Studies

Figure 10. Cutaneous Leishmaniasis Case Studies

Figure 11. Leishmaniasis Treatment Report Years Considered

Figure 12. Global Leishmaniasis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Leishmaniasis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Leishmaniasis Treatment Market Share by Region: 2023 VS 2030

Figure 15. Global Leishmaniasis Treatment Market Share by Players in 2023

Figure 16. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Leishmaniasis Treatment Revenue in 2023

Figure 18. North America Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Leishmaniasis Treatment Market Share by Country (2019-2030)

Figure 20. United States Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Leishmaniasis Treatment Market Share by Country (2019-2030)

Figure 24. Germany Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Leishmaniasis Treatment Market Share by Region (2019-2030)

Figure 32. China Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Leishmaniasis Treatment Market Share by Country (2019-2030)

Figure 40. Mexico Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Leishmaniasis Treatment Market Share by Country (2019-2030)

Figure 44. Turkey Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Merck Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)

Figure 47. iCo Therapeutics Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)

Figure 48. AEterna Zentaris Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)

Figure 49. AEterna Zentaris AG Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)

Figure 50. Eurofins Advinus Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)

Figure 51. Pieris Pharmaceuticals Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)

Figure 52. Dafra Pharma Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock